1. Home
  2. CNNE vs ARVN Comparison

CNNE vs ARVN Comparison

Compare CNNE & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNNE

Cannae Holdings Inc.

HOLD

Current Price

$14.83

Market Cap

609.0M

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.96

Market Cap

516.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNNE
ARVN
Founded
2014
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
609.0M
516.2M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
CNNE
ARVN
Price
$14.83
$8.96
Analyst Decision
Buy
Buy
Analyst Count
4
19
Target Price
$20.25
$15.05
AVG Volume (30 Days)
411.3K
835.4K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
4.47%
N/A
EPS Growth
N/A
58.84
EPS
0.12
1.70
Revenue
$499,700,000.00
$262,600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.28
Revenue Growth
3.37
N/A
52 Week Low
$10.46
$6.74
52 Week High
$19.88
$14.22

Technical Indicators

Market Signals
Indicator
CNNE
ARVN
Relative Strength Index (RSI) 53.76 61.46
Support Level $14.05 $7.90
Resistance Level $15.14 $9.65
Average True Range (ATR) 0.42 0.39
MACD -0.03 0.09
Stochastic Oscillator 67.83 62.11

Price Performance

Historical Comparison
CNNE
ARVN

About CNNE Cannae Holdings Inc.

Cannae Holdings Inc is an investment holding company that acquires and actively manages equity interests in operating businesses across various industries. The Company focuses on long-term ownership and seeks to create value by supporting the growth and operations of its portfolio companies through management expertise and strategic oversight. The Company operates through four reportable segments: Restaurant Group, which includes the operations of O'Charleys and 99 Restaurants; Alight, which represents its ownership interest in a technology-enabled human capital and employee benefits solutions provider; Black Knight Football Club (BKFC), which holds interests in professional football clubs; and JANA, which represents its investment in an investment management firm.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: